Literature DB >> 21584926

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.

Norman Kneteman1, Tito Livraghi, David Madoff, Eduardo de Santibañez, Michael Kew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21584926     DOI： 10.1002/lt.22334

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  12 in total

1.  Monitoring for post-transplant hepatocellular carcinoma recurrence.

Authors:  Jorge Ortiz; Jennifer Danniel; Mariana Chavez; Giovanni Davogustto
Journal:  HPB (Oxford)       Date:  2012-03-11       Impact factor: 3.647

2.  Twenty years of Milan criteria: how far do we go.

Authors:  Po-Chih Yang; Nobuhisa Akamatsu; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

Review 3.  Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.

Authors:  Bérénice Charrière; Charlotte Maulat; Bertrand Suc; Fabrice Muscari
Journal:  World J Hepatol       Date:  2016-07-28

Review 4.  Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future.

Authors:  Arturo Soriano; Aranzazu Varona; Rajesh Gianchandani; Modesto Enrique Moneva; Javier Arranz; Antonio Gonzalez; Manuel Barrera
Journal:  World J Hepatol       Date:  2016-01-08

5.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

6.  Survival of patients with hepatocellular carcinoma in the San Joaquin Valley: a comparison with California Cancer Registry data.

Authors:  Pradeep R Atla; Muhammad Y Sheikh; Ranjan Mascarenhas; Jayanta Choudhury; Paul Mills
Journal:  Ann Gastroenterol       Date:  2012

7.  Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.

Authors:  Yongin Cho; Myoung Soo Kim; Chung Mo Nam; Eun Seok Kang
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

8.  Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation.

Authors:  Deok Gie Kim; Jae Geun Lee; Dong Jin Joo; Soon Il Kim; Myoung Soo Kim
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

Review 9.  Liver Transplant Imaging prior to and during the COVID-19 Pandemic.

Authors:  Maria Irene Bellini; Daniele Fresilli; Augusto Lauro; Gianluca Mennini; Massimo Rossi; Carlo Catalano; Vito D'Andrea; Vito Cantisani
Journal:  Biomed Res Int       Date:  2022-01-12       Impact factor: 3.411

10.  Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.

Authors:  Marco Biolato; Giuseppe Marrone; Luca Miele; Antonio Gasbarrini; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.